Cytotoxic and Apoptotic Effects of the Combination of Borax (Sodium Tetraborate) and 5-Fluorouracil on DLD-1 Human Colorectal Adenocarcinoma Cell Line
- 31 August 2022
- journal article
- research article
- Published by Galenos Yayinevi in Turkish Journal of Pharmaceutical Sciences
- Vol. 19 (4) , 371-376
Abstract
Colorectal cancer (CRC) remains a crucial health problem due to the toxicity of 5-Fluorouracil (5-FU) as first-line chemotherapy agent for treating CRC. The anticancer effects of boron and its compounds have been shown in various cell lines. This study aimed to examine the cytotoxic and apoptotic effects of borax (sodium tetraborate) alone or along with 5-FU on human CRC cells, DLD-1. Cytotoxicity and apoptosis were determined by 3-(4,5-dimethylthiazolyl-2)-2,5-diphenyltetrazolium bromide (MTT) assay, 4’,6-diamidino-2-phenylindole and annexin V/propidium iodide staining. The results showed that combined treatment revealed a significant time- and concentration-dependent cytotoxic effect on DLD-1 cells compared with borax or 5-FU treatment alone. The combination of borax and 5-FU induced a clear increase in the early apoptotic cell percentage, compared to the cells treated with monotherapies. Additionally, a significant increase in condensed and fragmented nuclei was detected in DLD-1 cells treated with the combination treatment compared with borax or 5-FU alone. Our current findings suggest that the combination of borax with 5-FU has a strong cytotoxic and apoptotic effect on the human CRC DLD-1 cells.Keywords
This publication has 30 references indexed in Scilit:
- Chemoresistance in Prostate Cancer Cells Is Regulated by miRNAs and Hedgehog PathwayPLOS ONE, 2012
- Comparison of adverse events during 5‐fluorouracil versus 5‐fluorouracil/oxaliplatin adjuvant chemotherapy for stage III colon cancerCancer, 2012
- Balancing the efficacy and toxicity of chemotherapy in colorectal cancerTherapeutic Advances in Medical Oncology, 2010
- Inhibition of autophagy augments 5-fluorouracil chemotherapy in human colon cancer in vitro and in vivo modelEuropean Journal of Cancer, 2010
- Therapeutic Potential of Boron-Containing CompoundsFuture Medicinal Chemistry, 2009
- Oxaliplatin or Irinotecan As Adjuvant Therapy for Colon Cancer: The Results Are InJournal of Clinical Oncology, 2009
- Dietary Boron and Hormone Replacement Therapy as Risk Factors for Lung Cancer in WomenAmerican Journal of Epidemiology, 2008
- Comparative Effects of Boric Acid and Calcium Fructoborate on Breast Cancer CellsBiological Trace Element Research, 2008
- Boric acid inhibits human prostate cancer cell proliferationCancer Letters, 2004
- Global cancer statistics in the year 2000The Lancet Oncology, 2001